FACULTY AFFILIATIONS
Richard M Goldberg, MD
Professor and Chief
Division of Hematology/Oncology
Associate Director
University of North Carolina
Lineberger Comprehensive
Cancer Center
Chapel Hill, North Carolina
Axel Grothey, MD
Senior Associate Consultant
Department of Medical Oncology
Mayo Clinic
Rochester, Minnesota
Daniel G Haller, MD
Professor of Medicine
Abramson Cancer Center at the
University of Pennsylvania
Philadelphia, Pennsylvania |
Howard S Hochster, MD
Professor of Medicine and
Clinical Pharmacology
NYU Cancer Institute
New York, New York
Neal J Meropol, MD
Director, Gastrointestinal
Cancer Program
Director, Gastrointestinal Tumor Risk
Assessment Program
Divisions of Medical Science and
Population Science
Fox Chase Cancer Center
Philadelphia, Pennsylvania |
Alan P Venook, MD
Professor of Clinical Medicine
Associate Chief
Division of Medical Oncology
University of California
San Francisco
San Francisco, California
Norman Wolmark, MD
Professor and Chairman
Department of Human Oncology
Allegheny General Hospital
Professor, Drexel University
College of Medicine
Chairman, National Surgical
Adjuvant Breast and Bowel Project
Pittsburgh, Pennsylvania |
CONTENT VALIDATION AND DISCLOSURES
Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-
the-art education. We assess potential conflicts of interest with faculty, planners and managers of
CME activities. Real or apparent conflicts of interest are identified and resolved by a peer review content
validation process. The content of each activity is reviewed by both a member of the scientific staff
and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and
patient care recommendations.
The scientific staff and consultants for Research To Practice are involved in the development and
review of content for educational activities and report the following real or apparent conflicts of interest
for themselves (or their spouses/partners) that have been resolved through a peer review process:
John H Brebner, Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Michelle Paley, MD, Margaret
Peng, Lilliam Sklaver Poltorack, PharmD, Ginelle Suarez, Erin Wall and Kathryn Ault Ziel, PhD — no
real or apparent conflicts of interest to report; Sally Bogert, RNC, WHCNP — shareholder of Amgen
Inc and Genentech BioOncology. Research To Practice receives education grants from Abraxis
BioScience, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx
Pharmaceuticals Inc, Biogen Idec, Genentech BioOncology/OSI Pharmaceuticals Inc, Genomic Health
Inc, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of
our educational activities.
In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts
of interest that have been resolved through a peer review process:
Dr Goldberg — Consulting Fees: Amgen Inc, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH,
Bristol-Myers Squibb Company, Genentech BioOncology, ImClone Systems Inc, Pfizer Inc, Sanofi-Aventis.
Dr Grothey — Consulting Fees: Amgen Inc, Genentech BioOncology, Roche Laboratories Inc, Sanofi-Aventis. Dr Haller — Consulting Fees: Genentech BioOncology, Roche Laboratories Inc, Sanofi-Aventis; Contracted
Research: Bristol-Myers Squibb Company, Roche Laboratories Inc, Sanofi-Aventis. Dr Hochster — Consulting Fees: Amgen Inc, Genentech BioOncology, Roche Laboratories Inc, Sanofi-Aventis; Fees for Non-CME Services Received
Directly from Commercial Interest or Their Agents: Amgen Inc, Eli Lilly and Company, Genentech BioOncology,
Sanofi-Aventis. Dr Meropol — Consulting Fees: Amgen Inc, Genentech BioOncology, Pfizer Inc; Contracted
Research: Genentech BioOncology. Dr Venook — Consulting Fees: Sanofi-Aventis; Fees for Non-CME Services
Received Directly from Commercial Interest or Their Agents: Amgen Inc, Sanofi-Aventis; Contracted Research: Amgen Inc, Genentech BioOncology. Dr Wolmark — No financial interests or affiliations to disclose.
This educational activity contains discussion of published and/or investigational uses of agents that are
not indicated by the Food and Drug Administration. Research To Practice does not recommend the use
of any agent outside of the labeled indications. Please refer to the official prescribing information for each
product for discussion of approved indications, contraindications and warnings. The opinions expressed
are those of the presenters and are not to be construed as those of the publisher or grantors.
